Amedeo's Top 20

Amedeo Smart

Independent Medical Education

14 June 2021

Multidisciplinary Journal Club

  1. Radonovich LJ Jr, Simberkoff MS, Bessesen MT, Brown AC, et al.
    N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.
    JAMA 2019;322:824-833.

  1. Deng L, Chang TZ, Wang Y, Li S, et al.
    Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A 2018.

  2. Walker TA, Waite B, Thompson MG, McArthur C, et al.
    Risk of Severe Influenza among Adults with Chronic Medical Conditions.
    J Infect Dis 2019.

  3. Haasbach E, Muller C, Ehrhardt C, Schreiber A, et al.
    The MEK-inhibitor CI-1040 displays a broad anti-influenza activity in vitro and provides a prolonged treatment window compared to standard of care in vivo.
    Antiviral Res 2017.

  4. Isakova-Sivak I, Korenkov D, Smolonogina T, Tretiak T, et al.
    Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Virology 2016;500:209-217.

  1. Uehara T, Hayden FG, Kawaguchi K, Omoto S, et al.
    Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
    J Infect Dis 2019.

  2. Lin BSZ, Sur S, Liu P, Li Y, et al.
    Blood-brain barrier breakdown in relationship to Alzheimer and vascular disease.
    Ann Neurol 2021.

  3. Lewis CE, Fine LJ, Beddhu S, Cheung AK, et al.
    Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
    N Engl J Med 2021;384:1921-1930.

  4. Heinzel S, Aho VTE, Suenkel U, von Thaler AK, et al.
    Gut microbiome signatures of risk and prodromal markers of Parkinson's disease.
    Ann Neurol 2021.

  5. Palmqvist S, Tideman P, Cullen N, Zetterberg H, et al.
    Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.
    Nat Med 2021.

  1. Arya S, Naburi H, Kawaza K, Newton S, et al.
    Immediate "Kangaroo Mother Care" and Survival of Infants with Low Birth Weight.
    N Engl J Med 2021;384:2028-2038.

  2. Botwin GJ, Li D, Figueiredo J, Cheng S, et al.
    Adverse Events Following SARS-CoV-2 mRNA Vaccination: Among Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol 2021.

  3. Aktas O, Smith MA, Rees WA, Bennett JL, et al.
    Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
    Ann Neurol 2021;89:895-910.

  4. Schneider M, Hackert T, Strobel O, Buchler MW, et al.
    Technical advances in surgery for pancreatic cancer.
    Br J Surg 2021.

  5. Murphy CE, Wang RC, Montoy JC, Whittaker E, et al.
    Effect of Extended-Release Naltrexone on Alcohol Consumption: A Systematic Review and Meta-analysis.
    Addiction 2021.

  1. Hong Z, Tian C, Stewart T, Aro P, et al.
    Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying alpha-Synuclein-Containing Extracellular Vesicles.
    Neurology 2021;96:e2332-e2345.

  2. Hall RK, Blumenthal JB, Doerfler RM, Chen J, et al.
    Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Am J Kidney Dis 2021.

  3. Giannakeas V, Lim DW, Narod SA.
    The risk of contralateral breast cancer: a SEER-based analysis.
    Br J Cancer 2021.

  4. Soussain C, Malaise D, Cassoux N.
    Primary vitreoretinal lymphoma: A diagnostic and management challenge.
    Blood 2021.

  5. Khan N, Mahmud N.
    Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications.
    Gastroenterology 2021.


more..

Privacy Policy